ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology Specialist/Technologist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,982Medicare Part D Prescriptions Filled, Including Refills
$836K Total Retail Price of All Prescriptions
248 Patients Receiving at Least One Drug in Part D
49%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
RENVELA 521 202
CARVEDILOL 360 167
AMLODIPINE BESYLATE 331 160
SENSIPAR 319 83
LISINOPRIL 288 143
PRAVASTATIN SODIUM 271 125
ALLOPURINOL 257 191
CALCIUM ACETATE 236 19
CALCITRIOL 172 120
METOPROLOL TARTRATE 158 92
HYDRALAZINE HCL 155 67
PENTOXIFYLLINE 141 13
CLONIDINE HCL 133 11
CRESTOR 129 58
DOXAZOSIN MESYLATE 124 0
FUROSEMIDE 100 45
RISPERIDONE 96 80
OMEPRAZOLE 90 57
SIMVASTATIN 90 61
WARFARIN SODIUM 90 49
ULORIC 89 11
ISOSORBIDE DINITRATE 88 53
GABAPENTIN 86 61
MINOXIDIL 82 0
METOCLOPRAMIDE HCL 74 12
ATENOLOL 74 64
FAMOTIDINE 70 0
PANTOPRAZOLE SODIUM 68 18
LEVOTHYROXINE SODIUM 65 28
PREDNISONE 62 26
BISOPROLOL FUMARATE 58 0
LOVAZA 57 0
ALENDRONATE SODIUM 57 0
DIOVAN 57 0
GLYBURIDE 57 54 R
HYDROXYCHLOROQUINE SULFATE 54 14
DILTIAZEM ER 53 0
GUANFACINE HCL 52 0 R
VIREAD 51 0
AGGRENOX 51 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 30, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.